[
    [
        {
            "time": "",
            "original_text": "长春高新一季度净利润增长逾四成 获北上资金青睐",
            "features": {
                "keywords": [
                    "长春高新",
                    "一季度",
                    "净利润",
                    "增长",
                    "北上资金"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "长春高新一季度净利润增长逾四成 获北上资金青睐",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "长春高新：一季度净利润同比增46.26%",
            "features": {
                "keywords": [
                    "长春高新",
                    "一季度",
                    "净利润",
                    "同比",
                    "增长"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "长春高新：一季度净利润同比增46.26%",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "[增持评级] 医药生物行业周报：紧握高景气主线 注重估值匹配性",
            "features": {
                "keywords": [
                    "医药生物",
                    "周报",
                    "高景气",
                    "估值匹配性"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "[增持评级] 医药生物行业周报：紧握高景气主线 注重估值匹配性",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "东吴医药行业周观点：重点推荐医药细分领域业绩显著向上的OTC板块 建议关注片仔癀、济川药业、葵花药业等",
            "features": {
                "keywords": [
                    "东吴医药",
                    "周观点",
                    "OTC板块",
                    "业绩向上",
                    "片仔癀",
                    "济川药业",
                    "葵花药业"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物",
                    "OTC板块"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "东吴医药行业周观点：重点推荐医药细分领域业绩显著向上的OTC板块 建议关注片仔癀、济川药业、葵花药业等",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "基金1Q持仓分析(医疗保健行业)：1Q资金配置同比提升 聚焦长期逻辑通顺标的",
            "features": {
                "keywords": [
                    "基金",
                    "1Q",
                    "医疗保健",
                    "资金配置",
                    "同比提升",
                    "长期逻辑"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗保健"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "基金1Q持仓分析(医疗保健行业)：1Q资金配置同比提升 聚焦长期逻辑通顺标的",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]